Background of our project

Emissions of remedies

Full list of emissions of pharmaceuticals and curative plants: Actovegin, Allergy treatment, Arbidol, Deltaran, Dilacor, Esentiale, Fosamax, Liver treatment, Noni, Prednisolone, Preductal, Samprost, Soursop, Ursosan, Weight loss complex.


“...our notions of physical reality can never be final. We must always be ready to change these”

Albert Einstein.

In 1988 London journal “Nature”, whose prestige and reputation does not allow the desk to publish unconfirmed scientific reports, published an article written by a group of biologists led by French scientist Jacques Benveniste. The hardly understandable title of the article could leave the publication unnoticed, but the scientific world exploded.

“How can something act if it doesn’t exist?” - the respectable “Le Monde” asked. “Memory of the matter exists, but to transmit its properties via phone…”

“The results of J. Benveniste’s group are embarrassing” – responded one of the renowned chemists.

That is how the science and world public reacted to the news that J. Benveniste’s group conducted experiments on the transfer of substance's emission (properties) via telecommunications lines.

In 2011, the VI Annual Water Conference was held in USA (Vermont). The conference was attended by two Nobel laureates. The conference was devoted to the variety of properties and applications of water, and also it touched upon the issue that caused so much dispute back in 1988. Properties of a drug can be transmitted to a temporary carrier and then transferred via phone, Internet, and any other wired or wireless communication lines. All the advantages, all the power of a drug can be transmitted to an ordinary glass of water without any distortion! This means that you can get your dose of medicine from a glass of water standing on a CD, the latter in this case will serve as a temporary carrier.

Conference organizer, a renowned scientist Gerald Pollack, professor at Washington university (Seattle, WA) has invited DST Foundation scholars (non-commercial charitable organization) to present the project “Emission”.

PhD in Biological Sciences, Candidate* of Physical and Mathematical Sciences M.N. Zhadin; MD K.G. Hachumova; PhD B.P. Surinov; PhD in Technical Sciences V.V. Tsetlin; PhD N.V. Bobkova; PhD D.S. Stasytyte; PhD S.N. Novikov and other members of Scientific Committee of DST Foundation presented their materials to the conference. In the 90s of the 20th century, these materials could cause disputes, but at the conference they were accepted as scientific facts confirmed by practice and experiments.

Let me make a small digression.

About 3 years ago the Foundation started to work on a project that still doesn’t have a title, but which has already achieved some significant results recognized by the international scientific community.

One radiophysicist asked me to cooperate in the promotion of his invention. The essence of this invention consists in enabling a drug to be transmitted via communication lines, while retaining the qualities of this drug. Fantastic?!

Since then, dozens of tests and experiments were carried out. The feeling of some kind of fantasy still remains. However this is not a fantasy, but the facts. Again and again we receive confirmations that properties of the matter (for example, arbidol pills) can be transmitted via communication lines for thousands of miles.

In fact, it manifested development of a totally new product. I assume that the invention can cause disputes and discussion or even objections and attempts to discredit it. But the market will rule – nobody wants to lose their income.

Nonetheless, we are ready for discussion and examination as we have a strong evidence base and reviews of prominent scientists. We have a strong, professional team of practicing doctors and scientists, and we appreciate their difficult, but very important, brand new and highly productive activities.

As of today, we have over 1500 clinical observations, and almost all of them confirm promising and stable results.

Now, when we have facts in hand, we understand the necessity to promote this new product to the market. Our confidence in the feasibility of transmitting drugs electronically is strengthened by huge interest to this invention.

Now we cooperate with 23 doctors from Russia, Ukraine, Lithuania and USA, scientists from the Institute of Cell Biophysics of the Russian Academy of Sciences, National Research University of Electronic Technology, National Research Nuclear University MEPhI, The Russian State Medical University, Moscow Institute of Physics and Technology, FSUE Medical Radiological Research Center of Ministry of Health and Social Development of the Russian Federation, Institute of Human Ecology and Environmental Hygiene of Ministry of Health and Social Development of Moscow, Moscow State University, Prokhorov General Physics Institute of the Russian Academy of Sciences, and others.

Methodology is worked out, special devices are created. Patenting is in progress.

Great working and personal contacts are established between foreign colleagues from USA, Italy and Japan.

I hope you are interested to know more about our new product.

Best regards, Evgeny Germanov.

*In Russian academic system, PhD status is obtained in two stages: Candidate and PhD. The “Candidate” status suggests higher level of education than Master’s Degree, but lower than PhD. To obtain “Candidate” status one should complete higher education and conduct a research according to certain requirements. 

  • Emission

    The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

  • Artificial Blood Substitute

    Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

  • Cancer treatment

    Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.